FK 33-824

For research use only. Not for therapeutic Use.

  • CAT Number: I027498
  • CAS Number: 64854-64-4
  • Molecular Formula: C29H41N5O7S
  • Molecular Weight: 603.73
  • Purity: 98%
Inquiry Now

FK 33-824(Cat No.:I027498)is a potent small molecule inhibitor of the protein kinase CK2 (casein kinase 2), an enzyme involved in regulating various cellular processes, including cell growth, survival, and apoptosis. CK2 is often overexpressed in several cancers and is linked to tumor progression. By inhibiting CK2, FK 33-824 shows promise in reducing tumor cell proliferation and enhancing the sensitivity of cancer cells to other treatments. Preclinical studies have indicated its potential in treating cancers like leukemia and breast cancer. However, further clinical trials are necessary to assess its safety, efficacy, and therapeutic applications.


Catalog Number I027498
CAS Number 64854-64-4
Synonyms

FK 33-824; FK-33-824; FK33-824; SAN 33-824; Damme; Sandoz FK 33-824;

Molecular Formula C29H41N5O7S
Purity 98%
Solubility Soluble in DMSO
Appearance Solid powder
Storage Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
IUPAC Name (2S)-2-amino-N-[(2R)-1-[[2-[[(2S)-1-[[(2S)-1-hydroxy-4-methylsulfinylbutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-methylamino]-2-oxoethyl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide
InChI InChI=1S/C29H41N5O7S/c1-19(32-28(39)24(30)15-21-9-11-23(36)12-10-21)27(38)31-17-26(37)34(2)25(16-20-7-5-4-6-8-20)29(40)33-22(18-35)13-14-42(3)41/h4-12,19,22,24-25,35-36H,13-18,30H2,1-3H3,(H,31,38)(H,32,39)(H,33,40)/t19-,22+,24+,25+,42?/m1/s1
InChIKey HYZHONGSQNXMPH-IQNHEXCWSA-N
SMILES C[C@H](C(=O)NCC(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCS(=O)C)CO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N
Reference

1: Kaminski T. The involvement of protein kinases in signalling of opioid agonist FK 33-824 in porcine granulosa cells. Anim Reprod Sci. 2006 Jan;91(1-2):107-22. Epub 2005 Apr 25. PubMed PMID: 16310101.
2: Demura R, Suda T, Wakabayashi I, Yoshimura M, Jibiki K, Odagiri E, Demura H, Shizume K. Plasma pituitary hormone responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases. J Clin Endocrinol Metab. 1981 Feb;52(2):263-6. PubMed PMID: 7462391.
3: Peñalva A, Villanueva L, Casanueva F, Cavagnini F, Gomez-Pan A, Müller EE. Cholinergic and histaminergic involvement in the growth hormone releasing effect of an enkephalin analog FK 33-824 in man. Psychopharmacology (Berl). 1983;80(2):120-4. PubMed PMID: 6308703.
4: Scheurer U, Drack E, Varga L, Halter F. Morphine-like action of enkephalin analog FK 33-824 on motility of the isolated rat colon. J Pharmacol Exp Ther. 1981 Nov;219(2):534-9. PubMed PMID: 7288632.
5: Clark WG, Bernardini GL, Ponder SW. Extreme hyperthermia induced in cats by the enkephalin analog FK 33-824. Pharmacol Biochem Behav. 1982 Jun;16(6):989-93. PubMed PMID: 6287503.
6: Bevilacqua M, Vago T, Raggi U, Scorza D, Proverbio M, Malacco E, Norbiato G. In vitro steroidogenic properties of FK 33 824, a stable analog of methionine-enkephalin. Opiate-dopamine interaction in the control of aldosterone production. J Endocrinol Invest. 1982 Sep-Oct;5(5):277-80. PubMed PMID: 6296218.
7: Kaminski T, Siawrys G, Okrasa S, Przala J. Action of the opioid agonist FK 33-824 on porcine small and large luteal cells from the mid-luteal phase: effect on progesterone, cAMP, cGMP and inositol phosphate release. Anim Reprod Sci. 1999 Aug 16;56(3-4):245-57. PubMed PMID: 10497920.
8: del Pozo E, von Graffenried B, Brownell J, Derrer F, Marbach P. Endocrine effect of a methionine-enkephalin derivative (FK 33-824) in man. Horm Res. 1980;13(2):90-7. PubMed PMID: 6262206.
9: Gouardères C, Beaudet A, Zajac JM, Cros J, Quirion R. High resolution radioautographic localization of [125I]FK-33-824-labelled mu opioid receptors in the spinal cord of normal and deafferented rats. Neuroscience. 1991;43(1):197-209. PubMed PMID: 1717884.
10: Allolio B, Deuss U, Kaulen D, Leonhardt U, Kallabis D, Hamel E, Winkelmann W. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing’s disease. J Clin Endocrinol Metab. 1986 Dec;63(6):1427-31. PubMed PMID: 3023423.
11: Edens FW, Parkhurst CR. Plasma growth hormone and prolactin response to FK 33-824, a synthetic opioid agonist, in broiler chickens. Poult Sci. 1994 Nov;73(11):1746-54. PubMed PMID: 7862614.
12: Kaminski T. The response of phospholipase C/protein kinase C and adenylyl cyclase/protein kinase A pathways in porcine theca interna cells to opioid agonist FK 33-824. Domest Anim Endocrinol. 2004 Nov;27(4):379-96. PubMed PMID: 15519041.
13: Kaakkola S. Contralateral circling behaviour induced by intranigral injection of morphine and enkephalin analogue FK 33-824 in rats. Acta Pharmacol Toxicol (Copenh). 1980 Nov;47(5):385-93. PubMed PMID: 7197458.
14: Capogna M, Gähwiler BH, Thompson SM. Mechanism of mu-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro. J Physiol. 1993 Oct;470:539-58. PubMed PMID: 8308742; PubMed Central PMCID: PMC1143933.
15: Gosselin RE, Blankstein J, Dent DW, Hobson WC, Fuller GB, Reyes FI, Winter JS, Faiman C. Effects of naloxone and an enkephalin analog on serum prolactin, cortisol, and gonadotropins in the chimpanzee. Endocrinology. 1983 Jun;112(6):2168-73. PubMed PMID: 6406210.
16: Kandasamy SB, Williams BA. Hyperthermic effects of centrally injected (D-ala2, N-Me-Phe4, Met-(O)5-ol)-enkephalin (FK 33-824) in rabbits and guinea-pigs. Neuropharmacology. 1983 Oct;22(10):1177-81. PubMed PMID: 6316191.
17: Tremeau O, Faure G, Boulain JC, Bouet F, Menez A, Lecocq G, Morgat JL, Fromageot P. [Binding of a tritiated enkephalinergic analog (FK 33-824) to a mitochondrial fraction of rat brain]. Biochimie. 1981 Jun;63(6):477-84. French. PubMed PMID: 6266515.
18: Fjellner B, Hägermark O. Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK-33-824, beta-endorphin and morphine. Arch Dermatol Res. 1982;274(1-2):29-37. PubMed PMID: 6187298.
19: Jungkunz G, Nedopil N, Rüther E. Methysergide decreases prolactin release after FK 33-824 [Tyr-D-Ala-Gly-MePhe-Met(o)-ol], a potent analogue of methionine enkephalin. A study in man. Psychopharmacology (Berl). 1984;83(2):210-2. PubMed PMID: 6431476.
20: Zetler G, Raberg A. Ceruletide inhibits water intake in deprived mice: comparison with morphine and the enkephalin analogue, FK 33-824. Eur J Pharmacol. 1985 Aug 27;114(3):247-51. PubMed PMID: 2998807.

Request a Quote